Factor XIa inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9868727
SERIAL NO

15329634

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME LLC126 EAST LINCOLN AVENUE RAHWAY NJ 07065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ali, Amjad Freehold, US 82 315
Edmondson, Scott D Clark, US 48 672
Gao, Ying-Duo Holmdel, US 39 187
Guo, Zhuyan Scotch Plains, US 38 259
Jiang, Yu East Windsor, US 158 903
Kuang, Rongze Green Brook, US 33 112
Li, Chunsing Shanghai, CN 13 33
Liu, Weiguo Princeton, US 102 348
Ogawa, Anthony K New Providence, US 14 18
So, Sung-Sau Verona, US 76 300
Wu, Heping Edison, US 22 70
Yu, Tingting Shanghai, CN 45 103

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 16, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 16, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00